Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) and Allogene Therapeutics (NASDAQ:ALLO – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, profitability, analyst recommendations, institutional ownership, valuation and dividends. Institutional and Insider Ownership 27.0% of Sorrento Therapeutics shares […]